Live from the NIH registry
Studies recruiting near Hartford right now
Top 25 of 437 recruiting studies, sorted by proximity — each links to its official registry page
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Hartford Hospital — Hartford, Connecticut (0.2 mi)
· Sponsor: American Society of Clinical Oncology
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Hartford Hospital — Hartford, Connecticut (0.2 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Smilow Cancer Hospital Care Center at Saint Francis — Hartford, Connecticut (0.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
OssiMend BA in Posterolateral Instrumented Lumbar Fusion
Spinal Disease, Degenerative Disc Disease
N/A
Observational 120 participants sought
Hartford Hospital — Hartford, Connecticut (0.2 mi)
· Sponsor: Collagen Matrix
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (0.2 mi)
· Sponsor: National Cancer Institute (NCI)
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Alcohol Use Disorder, Cannabis Use Disorder
N/A
Interventional 294 participants sought
UConn Health — Farmington, Connecticut (8.3 mi)
· Sponsor: Massachusetts General Hospital
CLOZAPINE Response in Biotype-1
Schizophrenia, Schizoaffective Disorder
Phase 4
Interventional 524 participants sought
Hartford Healthcare — Hartford, Connecticut (0.2 mi)
· Sponsor: University of Texas Southwestern Medical Center
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
Agitation
Phase 2
Interventional 150 participants sought
Elixia MA, LLC — Springfield, Massachusetts (23.7 mi)
· Sponsor: Teikoku Pharma USA, Inc.
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
Pediatric Cancer
N/A
Observational 35 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (0.2 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
Hartford Hospital — Hartford, Connecticut (0.2 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
Hartford HealthCare Cancer Institute — Hartford, Connecticut (0.2 mi)
· Sponsor: Kura Oncology, Inc.
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Phase 2
Interventional 40 participants sought
Uconn Health — Farmington, Connecticut (8.3 mi)
· Sponsor: Incyte Corporation
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
Gastroenterolgy Center of Conneticut — Hamden, Connecticut (27.9 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
Phase 3
Interventional 120 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (0.2 mi)
· Sponsor: Janssen Research & Development, LLC
Motivating Increases in Physical Activity for Prevention of Weight Regain After Metabolic Bariatric Surgery
Obesity
N/A
Interventional 164 participants sought
Hartford HealthCare — Hartford, Connecticut (0.2 mi)
· Sponsor: Hartford Hospital
A Novel Program Using Ride-on Toys to Improve Upper Extremity Function in Children With Hemiplegia
Hemiplegia, Cerebral Palsy
N/A
Interventional 30 participants sought
Physical Therapy Program, Department of Kinesiology, University of Connecticut — Storrs, Connecticut (22.5 mi)
· Sponsor: University of Connecticut
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — Waterbury, Connecticut (23.8 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
Metastatic Ewing Sarcoma
Phase 1
Interventional 15 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (0.2 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Smilow Cancer Hospital Care Center at Saint Francis — Hartford, Connecticut (0.2 mi)
· Sponsor: SWOG Cancer Research Network
Open Versus Arthroscopic Stabilization of Shoulder Instability With Subcritical Bone Loss: The OASIS Trial
Shoulder Dislocation, Glenohumeral Dislocation
N/A
Observational 450 participants sought
University of Connecticut Health Center — Farmington, Connecticut (8.3 mi)
· Sponsor: University of Pittsburgh
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 798 participants sought
Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut — Plainville, Connecticut (11.0 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Continuous Positive Airway Pressure, Arousability and Links to Mechanisms in Obstructive Sleep Apnea
Sleep Apnea, Obstructive Sleep Apnea
Phase 3
Interventional 250 participants sought
Yale Centers for Sleep Medicine — North Haven, Connecticut (27.5 mi)
· Sponsor: Yale University
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Medical Research Center of Connecticut — Hamden, Connecticut (27.9 mi)
· Sponsor: Eli Lilly and Company
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Knee Osteoarthritis (OA)
Phase 3
Interventional 400 participants sought
Chase Medical Research LLC — Waterbury, Connecticut (23.8 mi)
· Sponsor: Novo Nordisk A/S
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (0.2 mi)
· Sponsor: National Cancer Institute (NCI)